Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Mark Pruzanski. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Mark Pruzanski har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ICPT / Intercept Pharmaceuticals Inc | Director | 0 |
US:EQ / Equillium, Inc. | Director | 20 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Mark Pruzanski. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp EQ / Equillium, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i EQ / Equillium, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i EQ / Equillium, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Mark Pruzanski som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-11-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
U - Other | −618 894 | 0 | −100,00 | 19,00 | −11 758 986 | ||
2022-05-25 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2021-12-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 817 | 618 894 | −0,61 | 17,21 | −65 691 | 10 651 166 | |
2021-12-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 622 711 | 1,00 | 17,21 | 105 635 | 10 716 856 | |
2021-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 817 | 616 573 | −0,62 | 16,86 | −64 355 | 10 395 421 | |
2021-11-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 620 390 | 1,00 | 16,86 | 103 487 | 10 459 775 | |
2021-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 816 | 614 252 | −0,62 | 14,85 | −56 668 | 9 121 642 | |
2021-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 136 | 618 068 | 1,00 | 14,85 | 91 120 | 9 178 310 | |
2021-09-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 817 | 611 932 | −0,62 | 14,91 | −56 911 | 9 123 906 | |
2021-09-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 615 749 | 1,01 | 14,91 | 91 518 | 9 180 818 | |
2021-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 817 | 609 611 | −0,62 | 17,28 | −65 958 | 10 534 078 | |
2021-08-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 613 428 | 1,01 | 17,28 | 106 065 | 10 600 036 | |
2021-07-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 816 | 607 290 | −0,62 | 19,97 | −76 206 | 12 127 581 | |
2021-07-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 136 | 611 106 | 1,01 | 19,97 | 122 536 | 12 203 787 | |
2021-06-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 817 | 604 970 | −0,63 | 16,63 | −63 477 | 10 060 651 | |
2021-06-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 608 787 | 1,02 | 16,63 | 102 075 | 10 124 128 | |
2021-05-28 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 20 770 | 20 770 | |||||
2021-05-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 817 | 502 649 | −0,75 | 19,78 | −75 500 | 9 942 397 | |
2021-05-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 506 466 | 1,23 | 19,78 | 121 410 | 10 017 897 | |
2021-04-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 658 | 500 328 | −0,73 | 23,08 | −84 427 | 11 547 570 | |
2021-04-01 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 136 | 503 986 | 1,23 | 23,08 | 141 619 | 11 631 997 | |
2021-03-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −2 741 | 497 850 | −0,55 | 21,66 | −59 370 | 10 783 431 | |
2021-03-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 500 591 | 1,24 | 21,66 | 132 949 | 10 842 801 | |
2021-02-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −2 741 | 494 453 | −0,55 | 35,24 | −96 593 | 17 424 524 | |
2021-02-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6 138 | 497 194 | 1,25 | 35,24 | 216 303 | 17 521 117 | |
2021-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −632 | 491 056 | −0,13 | 24,70 | −15 610 | 12 129 083 | |
2021-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −25 065 | 491 688 | −4,85 | 24,70 | −619 106 | 12 144 694 | |
2021-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 41 236 | 516 753 | 8,67 | 24,70 | 1 018 529 | 12 763 799 | |
2020-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −772 | 475 517 | −0,16 | 42,08 | −32 486 | 20 009 755 | |
2020-07-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −772 | 476 289 | −0,16 | 46,52 | −35 913 | 22 156 964 | |
2020-05-21 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 24 000 | 24 000 | |||||
2020-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −568 | 477 061 | −0,12 | 58,40 | −33 171 | 27 860 362 | |
2020-01-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
A - Award | 17 700 | 17 700 | |||||
2020-01-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10 800 | 477 629 | 2,31 | ||||
2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 166 | 466 829 | −0,25 | 123,92 | −144 491 | 57 849 450 | |
2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −100 | 30 084 | −0,33 | |||
2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 131 | 467 995 | −0,24 | 123,92 | −140 154 | 57 993 940 | |
2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −100 | 469 126 | −0,02 | 125,00 | −12 500 | 58 640 750 |
2020-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 100 | 469 226 | 0,02 | 21,50 | 2 150 | 10 088 359 |
2019-12-30 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −417 | 30 184 | −1,36 | |||
2019-12-30 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −417 | 469 126 | −0,09 | 125,00 | −52 125 | 58 640 750 |
2019-12-30 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 417 | 469 543 | 0,09 | 21,50 | 8 966 | 10 095 174 |
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −15 557 | 30 601 | −33,70 | |||
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −19 880 | 0 | −100,00 | |||
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −35 437 | 469 126 | −7,02 | 100,00 | −3 543 700 | 46 912 600 |
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 15 557 | 504 563 | 3,18 | 21,50 | 334 476 | 10 848 104 |
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 19 880 | 489 006 | 4,24 | 8,67 | 172 294 | 4 238 068 |
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −14 524 | 19 880 | −42,22 | |||
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −39 | 0 | −100,00 | |||
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −14 563 | 469 126 | −3,01 | 100,00 | −1 456 300 | 46 912 600 |
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 14 524 | 483 689 | 3,10 | 8,67 | 125 875 | 4 191 987 |
2019-11-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 39 | 469 165 | 0,01 | 8,67 | 338 | 4 066 112 |
2019-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 547 | 469 126 | −0,33 | 65,87 | −101 901 | 30 901 330 | |
2019-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 548 | 470 673 | −0,33 | 79,17 | −122 555 | 37 263 181 | |
2019-06-13 |
|
4 | EQ |
Equillium, Inc.
Stock Option (right to buy) |
A - Award | 12 000 | 12 000 | |||||
2019-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 547 | 472 221 | −0,33 | 111,50 | −172 490 | 52 652 642 | |
2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
A - Award | 13 700 | 13 700 | |||||
2019-01-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8 500 | 573 768 | 1,50 | ||||
2019-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −1 537 | 565 268 | −0,27 | 100,79 | −154 914 | 56 973 362 | |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −27 606 | 39 | −99,86 | |||
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −1 988 | 566 805 | −0,35 | 103,29 | −205 333 | 58 543 021 |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 839 | 568 793 | −1,36 | 102,61 | −804 374 | 58 364 874 |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −7 949 | 576 632 | −1,36 | 101,48 | −806 687 | 58 518 230 |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −9 830 | 584 581 | −1,65 | 100,38 | −986 735 | 58 680 241 |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 27 606 | 594 411 | 4,87 | 8,67 | 239 253 | 5 151 582 |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock |
M - Exercise | X | −22 394 | 27 645 | −44,75 | |||
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −3 521 | 566 805 | −0,62 | 101,13 | −356 088 | 57 322 520 |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
S - Sale | X | −18 873 | 570 326 | −3,20 | 100,38 | −1 894 496 | 57 250 065 |
2018-11-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | X | 22 394 | 589 199 | 3,95 | 8,67 | 194 082 | 5 106 411 |
2018-10-11 | 3 | EQ |
Equillium, Inc.
Common Stock |
47 598 | ||||||||
2018-10-11 | 3 | EQ |
Equillium, Inc.
Common Stock |
47 598 | ||||||||
2018-10-11 | 3 | EQ |
Equillium, Inc.
Common Stock |
47 598 | ||||||||
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −2 049 | 566 805 | −0,36 | 126,46 | −259 117 | 71 678 160 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −2 051 | 566 805 | −0,36 | 83,91 | −172 099 | 47 560 608 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −2 050 | 566 805 | −0,36 | 61,52 | −126 116 | 34 869 844 | |
2018-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS, INC.
Common Stock |
F - Taxes | −3 609 | 566 805 | −0,63 | 58,42 | −210 838 | 33 112 748 | |
2018-04-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 812 | 576 564 | 1,37 | 64,00 | 499 968 | 36 900 096 | |
2018-02-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 45 500 | 45 500 | |||||
2017-10-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 532 | 568 752 | −0,27 | 58,87 | −90 189 | 33 482 430 | |
2017-07-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 434 | 570 284 | −0,25 | 121,78 | −174 633 | 69 449 186 | |
2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −40 000 | 50 039 | −44,43 | |||
2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 043 | 571 718 | −0,36 | 133,07 | −271 872 | 76 081 316 |
2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 485 | 573 761 | −0,95 | 132,54 | −726 996 | 76 047 717 |
2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 893 | 579 246 | −1,01 | 131,18 | −773 050 | 75 986 070 |
2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 763 | 585 139 | −3,11 | 130,46 | −2 447 845 | 76 337 995 |
2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 816 | 603 902 | −1,28 | 129,49 | −1 012 101 | 78 199 813 |
2017-06-28 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 40 000 | 611 718 | 7,00 | 8,67 | 346 668 | 5 301 576 |
2017-04-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 | 571 718 | 0,00 | 115,00 | −137 | 65 746 026 | |
2017-02-14 |
|
5 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
G - Gift | −3 000 | 572 905 | −0,52 | ||||
2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 40 000 | 40 000 | |||||
2017-02-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 23 200 | 575 905 | 4,20 | ||||
2017-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 802 | 552 705 | −0,50 | 103,92 | −291 181 | 57 436 606 | |
2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −2 405 | 1 354 | −63,98 | ||||
2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −1 082 | 0 | −100,00 | ||||
2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 405 | 555 507 | 0,43 | 31,90 | 76 720 | 17 720 673 | |
2016-12-08 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 082 | 553 102 | 0,20 | 21,50 | 23 263 | 11 891 693 | |
2016-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −705 | 552 020 | −0,13 | 163,20 | −115 056 | 90 089 498 | |
2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −8 411 | 0 | −100,00 | |||
2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −26 589 | 90 039 | −22,80 | |||
2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −35 000 | 552 725 | −5,96 | 165,00 | −5 775 000 | 91 199 625 |
2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 8 411 | 587 725 | 1,45 | 9,82 | 82 615 | 5 772 811 |
2016-09-22 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 26 589 | 579 314 | 4,81 | 8,67 | 230 439 | 5 020 741 |
2016-07-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −12 500 | 0 | −100,00 | ||||
2016-07-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
F - Taxes | −7 341 | 552 725 | −1,31 | 148,73 | −1 091 827 | 82 206 789 | |
2016-07-19 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 500 | 560 066 | 2,28 | 9,82 | 122 779 | 5 501 136 | |
2016-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −714 | 547 566 | −0,13 | 145,11 | −103 608 | 79 456 864 | |
2016-04-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −708 | 548 248 | −0,13 | 130,76 | −92 578 | 71 688 908 | |
2016-02-16 |
|
5 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
G - Gift | −3 900 | 548 956 | −0,71 | ||||
2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 30 500 | 30 500 | |||||
2016-02-12 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 23 300 | 552 856 | 4,40 | ||||
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −125 | 529 556 | −0,02 | 145,90 | −18 238 | 77 264 180 | |
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 001 | 529 681 | −0,38 | 145,90 | −291 953 | 77 282 418 | |
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 0 | −100,00 | ||||
2016-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 531 682 | 0,92 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −167 | 526 814 | −0,03 | 159,04 | −26 560 | 83 784 130 | |
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −4 867 | 4 868 | −49,99 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 32 550 | 32 550 | |||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 867 | 526 981 | 0,93 | ||||
2015-10-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 15 100 | 522 114 | 2,98 | ||||
2015-07-14 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −12 500 | 116 628 | −9,68 | |||
2015-07-14 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 500 | 507 014 | −2,41 | 250,00 | −3 125 000 | 126 753 500 |
2015-07-14 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 519 514 | 2,47 | 8,67 | 108 334 | 4 502 472 |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 | 507 014 | 0,00 | 239,00 | −478 | 121 176 397 | |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −7 | 507 016 | 0,00 | 238,16 | −1 667 | 120 750 981 | |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −149 | 507 023 | −0,03 | 236,13 | −35 183 | 119 723 341 | |
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 9 735 | −33,34 | ||||
2015-07-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 507 172 | 0,97 | ||||
2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −4 651 | 47 240 | −8,96 | ||||
2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −1 910 | 34 404 | −5,26 | ||||
2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 651 | 502 304 | 0,93 | 21,50 | 99 996 | 10 799 536 | |
2015-06-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 910 | 497 653 | 0,39 | 8,67 | 16 553 | 4 313 009 | |
2015-05-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −5 000 | 129 128 | −3,73 | |||
2015-05-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 495 743 | −1,00 | 300,00 | −1 500 000 | 148 722 900 |
2015-05-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 500 743 | 1,01 | 8,67 | 43 334 | 4 339 789 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −12 500 | 134 128 | −8,52 | |||
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −312 | 495 743 | −0,06 | 259,33 | −80 912 | 128 563 114 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 496 055 | −0,08 | 258,50 | −103 400 | 128 230 218 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 496 455 | −0,04 | 256,42 | −51 283 | 127 298 509 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −661 | 496 655 | −0,13 | 255,49 | −168 881 | 126 892 025 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 539 | 497 316 | −0,31 | 254,63 | −391 881 | 126 633 264 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 338 | 498 855 | −0,86 | 253,52 | −1 099 791 | 126 472 114 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 350 | 503 193 | −0,66 | 252,53 | −845 979 | 127 071 781 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 700 | 506 543 | −0,33 | 251,39 | −427 368 | 127 341 466 |
2015-05-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 508 243 | 2,52 | 8,67 | 108 334 | 4 404 790 |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −157 | 495 743 | −0,03 | 277,70 | −43 599 | 137 668 129 | |
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 14 603 | −25,00 | ||||
2015-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 495 900 | 0,99 | ||||
2015-01-07 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | −461 | 491 032 | −0,09 | 176,49 | −81 360 | 86 660 126 | |
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 19 471 | −20,00 | ||||
2015-01-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 491 493 | 1,00 | ||||
2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −31 | 51 891 | −0,06 | ||||
2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −6 685 | 36 314 | −15,55 | ||||
2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 31 | 486 625 | 0,01 | 21,50 | 666 | 10 462 438 | |
2014-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 685 | 486 594 | 1,39 | 8,67 | 57 937 | 4 217 164 | |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −10 000 | 146 628 | −6,38 | |||
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 479 909 | −0,10 | 262,46 | −131 231 | 125 957 876 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 950 | 480 409 | −0,61 | 261,71 | −772 034 | 125 726 110 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 166 | 483 359 | −0,65 | 260,68 | −825 300 | 126 000 091 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 486 525 | −0,23 | 259,47 | −285 420 | 126 239 955 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 487 625 | −0,08 | 257,96 | −103 184 | 125 787 745 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 488 025 | −0,04 | 256,54 | −51 308 | 125 196 713 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 488 225 | −0,06 | 255,30 | −76 589 | 124 642 231 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 488 525 | −0,10 | 254,29 | −127 146 | 124 227 755 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 489 025 | −0,06 | 252,90 | −75 870 | 123 674 422 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −384 | 489 325 | −0,08 | 250,80 | −96 308 | 122 723 738 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 489 709 | −0,02 | 249,69 | −24 969 | 122 275 440 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 489 809 | −0,02 | 247,66 | −24 766 | 121 306 097 |
2014-11-05 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 489 909 | 2,08 | 8,67 | 86 667 | 4 245 894 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −10 000 | 156 628 | −6,00 | |||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 867 | 24 339 | −16,66 | ||||
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 479 909 | −0,04 | 234,94 | −46 987 | 112 748 045 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 480 109 | −0,02 | 233,74 | −23 374 | 112 220 678 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 480 209 | −0,06 | 232,15 | −69 645 | 111 480 519 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 480 509 | −0,15 | 231,31 | −161 920 | 111 148 603 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 481 209 | −0,12 | 230,30 | −138 181 | 110 823 251 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 750 | 481 809 | −0,36 | 229,30 | −401 272 | 110 477 840 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 500 | 483 559 | −0,72 | 228,45 | −799 578 | 110 469 537 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 450 | 487 059 | −0,30 | 227,64 | −330 082 | 110 875 621 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 400 | 488 509 | −0,29 | 226,53 | −317 147 | 110 663 751 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 489 909 | 2,08 | 8,67 | 86 667 | 4 245 894 |
2014-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 867 | 479 909 | 1,02 | ||||
2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −10 000 | 166 628 | −5,66 | |||
2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 475 042 | −0,04 | 289,72 | −57 943 | 137 626 793 |
2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −800 | 475 242 | −0,17 | 288,16 | −230 532 | 136 948 111 |
2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 600 | 476 042 | −0,33 | 287,48 | −459 969 | 136 852 983 |
2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 800 | 477 642 | −0,79 | 286,42 | −1 088 410 | 136 807 989 |
2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 600 | 481 442 | −0,74 | 285,56 | −1 028 028 | 137 482 214 |
2014-09-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 485 042 | 2,11 | 8,67 | 86 667 | 4 203 714 |
2014-08-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −10 000 | 176 628 | −5,36 | |||
2014-08-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 475 042 | −2,06 | 226,72 | −2 267 198 | 107 701 427 |
2014-08-06 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 485 042 | 2,11 | 8,67 | 86 667 | 4 203 714 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −10 000 | 186 628 | −5,09 | |||
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 29 206 | −14,29 | ||||
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 475 042 | −2,06 | 250,61 | −2 506 121 | 119 051 273 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 485 042 | 2,11 | 8,67 | 86 667 | 4 203 714 |
2014-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 868 | 475 042 | 1,04 | ||||
2014-06-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 196 628 | −4,84 | |||
2014-06-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 470 174 | −2,08 | 230,60 | −2 305 993 | 108 421 795 |
2014-06-04 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 480 174 | 2,13 | 8,67 | 86 667 | 4 161 524 |
2014-05-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 206 628 | −4,62 | |||
2014-05-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 470 174 | −2,08 | 263,17 | −2 631 661 | 123 733 858 |
2014-05-02 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 480 174 | 2,13 | 8,67 | 86 667 | 4 161 524 |
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | X | −10 000 | 216 628 | −4,41 | |||
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 470 174 | −2,08 | 242,22 | −2 422 166 | 113 883 948 |
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 480 174 | 2,13 | 8,67 | 86 667 | 4 161 524 |
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −2 866 | 42 999 | −6,25 | ||||
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −14 332 | 226 628 | −5,95 | ||||
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Option to Purchase Common Stock |
M - Exercise | −13 111 | 0 | −100,00 | ||||
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 2 866 | 470 174 | 0,61 | 8,67 | 24 839 | 4 074 857 | |
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 332 | 467 308 | 3,16 | 8,67 | 124 211 | 4 050 018 | |
2014-04-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
M - Exercise | 13 111 | 452 976 | 2,98 | 2,89 | 37 876 | 1 308 602 | |
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 22 931 | 22 931 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 5 733 | 5 733 | |||||
2014-04-15 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
A - Award | 4 699 | 439 865 | 1,08 | ||||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 34 074 | −12,50 | ||||
2014-04-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 868 | 435 166 | 1,13 | ||||
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −10 000 | 240 960 | −3,98 | |||
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 000 | 430 298 | −2,27 | 273,68 | −2 736 767 | 117 762 537 |
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 10 000 | 440 298 | 2,32 | 8,67 | 86 667 | 3 815 931 |
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −12 850 | 13 111 | −49,50 | ||||
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | −8 653 | 0 | −100,00 | ||||
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 12 850 | 438 138 | 3,02 | 2,89 | 37 122 | 1 265 737 | |
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 653 | 425 288 | 2,08 | 2,89 | 24 998 | 1 228 615 | |
2014-01-17 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
G - Gift | −7 840 | 430 298 | −1,79 | ||||
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 38 942 | −11,11 | ||||
2014-01-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 868 | 416 635 | 1,18 | ||||
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 867 | 43 810 | −10,00 | ||||
2013-10-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 867 | 406 899 | 1,21 | ||||
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −12 500 | 20 911 | −37,41 | |||
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −12 500 | 20 911 | −37,41 | |||
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −25 000 | 402 032 | −5,85 | 52,00 | −1 300 000 | 20 905 664 |
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 500 | 427 032 | 3,02 | 9,82 | 122 779 | 4 194 436 |
2013-09-18 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 500 | 427 032 | 3,02 | 9,82 | 122 779 | 4 194 436 |
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −7 694 | 33 411 | −18,72 | |||
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 906 | 12 500 | −23,81 | |||
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −9 804 | 402 032 | −2,38 | 49,05 | −480 886 | 19 719 670 |
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 796 | 411 836 | −0,43 | 48,51 | −87 124 | 19 978 164 |
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 7 694 | 413 632 | 1,90 | 9,82 | 75 573 | 4 062 818 |
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 906 | 405 938 | 0,97 | 9,82 | 38 366 | 3 987 245 |
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −900 | 16 406 | −5,20 | |||
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −900 | 402 032 | −0,22 | 49,65 | −44 684 | 19 960 487 |
2013-09-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 900 | 402 932 | 0,22 | 9,82 | 8 840 | 3 957 719 |
2013-08-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −12 500 | 17 306 | −41,94 | |||
2013-08-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −12 500 | 402 032 | −3,02 | 45,98 | −574 724 | 18 484 587 |
2013-08-13 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 500 | 414 532 | 3,11 | 9,82 | 122 779 | 4 071 658 |
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −21 700 | 29 806 | −42,13 | |||
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 659 | 402 032 | −0,41 | 50,64 | −84 008 | 20 357 976 |
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −20 041 | 403 691 | −4,73 | 49,78 | −997 675 | 20 096 424 |
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 21 700 | 423 732 | 5,40 | 9,82 | 213 144 | 4 162 023 |
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −3 300 | 51 506 | −6,02 | |||
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 300 | 402 032 | −0,32 | 51,83 | −67 374 | 20 835 670 |
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 000 | 403 332 | −0,49 | 51,04 | −102 072 | 20 584 412 |
2013-07-16 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 300 | 405 332 | 0,82 | 9,82 | 32 414 | 3 981 293 |
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −10 097 | 54 806 | −15,56 | |||
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −2 403 | 0 | −100,00 | |||
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −12 500 | 402 032 | −3,02 | 48,26 | −603 259 | 19 402 346 |
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 10 097 | 414 532 | 2,50 | 9,82 | 99 176 | 4 071 658 |
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 403 | 404 435 | 0,60 | 9,82 | 23 603 | 3 972 482 |
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −25 000 | 2 403 | −91,23 | |||
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −25 000 | 402 032 | −5,85 | 45,41 | −1 135 200 | 18 255 469 |
2013-07-10 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 25 000 | 427 032 | 6,22 | 9,82 | 245 558 | 4 194 436 |
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −4 868 | 48 677 | −9,09 | ||||
2013-07-03 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 4 868 | 406 900 | 1,21 | ||||
2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −12 300 | 27 403 | −30,98 | |||
2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −12 300 | 402 032 | −2,97 | 40,06 | −492 745 | 16 105 643 |
2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 300 | 414 332 | 3,06 | 9,82 | 120 814 | 4 069 693 |
2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −200 | 39 703 | −0,50 | |||
2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 402 032 | −0,05 | 40,00 | −8 000 | 16 081 280 |
2013-06-27 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 200 | 402 232 | 0,05 | 9,82 | 1 964 | 3 950 843 |
2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −16 000 | 39 903 | −28,62 | |||
2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −16 000 | 402 032 | −3,83 | 38,35 | −613 597 | 15 417 847 |
2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 16 000 | 418 032 | 3,98 | 9,82 | 157 157 | 4 106 036 |
2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
M - Exercise | X | −9 000 | 55 903 | −13,87 | |||
2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
S - Sale | X | −9 000 | 402 032 | −2,19 | 38,08 | −342 751 | 15 310 745 |
2013-06-21 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 9 000 | 411 032 | 2,24 | 9,82 | 88 401 | 4 037 280 |
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 65 000 | 65 000 | |||||
2013-05-09 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
A - Award | 7 700 | 402 032 | 1,95 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −24 339 | 53 545 | −31,25 | ||||
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
F - Taxes | −10 774 | 394 332 | −2,66 | 34,57 | −372 457 | 13 632 057 | |
2013-04-11 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common stock |
M - Exercise | 24 339 | 405 106 | 6,39 | ||||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Options to Purchase Common Stock |
A - Award | 51 922 | 51 922 | |||||
2012-11-20 |
|
4 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 77 884 | 77 884 | |||||
2012-10-10 | 3 | ICPT |
INTERCEPT PHARMACEUTICALS INC
Common Stock |
380 767 |